Insider Trends: Bristol-Myers Squibb Sees 90 Days of Insider Buying Trend Reducing with Share Sale
04:42 PM EDT, 05/11/2021 (MT Newswires) -- Louis S Schmukler, EVP,Pres.,Glob.Prod. & Supply, sold 15,000 shares in Bristol-Myers Squibb (BMY) for $978,750 on May 10, 2021. Following the Form 4 filing with the SEC, Schmukler has 31,956 shares of the company, which have a market value of $2.07 million as of the prior-day closing price.
In the 90 days prior to the date of this filing, there have been 17 insider transactions reported to the SEC for Bristol-Myers Squibb. These transactions came from the activities of 13 individual insiders that resulted in a net acquisition of 170,477 company shares. Relative to the preceding 90-day window of time, there were 24 transactions from 7 insiders that resulted in the net acquisition of 5,692 shares.
This is a lower level of transactions than the peer group average in the 150-company Pharmaceuticals peer group over the last 90-day period. Within the peer group activity averaged 64.5 transactions per company, and disposition of 7,234 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/14272/000001427221000135/xslF345X03/wf-form4_162076553809722.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.